The “Global Liquid Handling System Market by Product (Pipette, Consumables, Liquid Handling Workstations, Burettes, Software), Type (Automated,…
Author: admin
Cryogenic Vials Market size to grow by USD 66.16 million from 2022 to 2027, North America to account for 36% of the market growth – TechnavioHealth Care & Hospitals
The latest report on the cryogenic vials market, 2023-2027 estimates to register an incremental growth of USD 66.16 million, almost at…
Shorla Oncology & EVERSANA Announce Commercial Launch of Recent FDA-Approved Nelarabine Injection for the Treatment of T-cell Leukemia Across the United States
Shorla Oncology (‘Shorla’), a U.S.-Irelandpharmaceutical company, and EVERSANA®, a leading provider of commercialization services to the life science…
Surgo Health Study Offers New AI-Driven Insights into COVID-19 Vaccine Decision-Making
Surgo Health, a new healthcare technology company dedicated to personalized healthcare, today announced that original data…
Phio Pharmaceuticals Announces FDA Clearance to Initiate Clinical Trial of PH-762 for Treatment of Skin Carcinomas
Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company whose proprietary INTASYL™ RNAi platform technology is designed…
USDA honors Texas A&M’s Patrick J. Stover, director of Institute for Advancing Health Through Agricultur
Patrick J. Stover, Ph.D., director of the Texas A&M Institute for Advancing Health through Agriculture (IHA), has been named…
MediBeacon Inc. Appoints Dr. Steve Miller as Chief Medical Officer
MediBeacon Inc., a portfolio company within the Pansend Life Sciences segment of INNOVATE Corp. (NYSE: VATE), today announced the…
Intergalactic Therapeutics to Host Virtual KOL Investor Event on May 23, 2023
Intergalactic Therapeutics, a company focused on transforming medicine through non-viral gene therapy, announced today that it…
Positive Topline Clinical Results Support Streamlined Development Pathway for LPCN 1154, Lipocine’s Oral Candidate for Rapid Relief of Depression
Lipocine Inc. (NASDAQ: LPCN), today announced positive topline results from a pilot clinical PK bridge study of…
CASI PHARMACEUTICALS ANNOUNCES FIRST QUARTER 2023 FINANCIAL RESULTS
CASI Pharmaceuticals, Inc. (Nasdaq: CASI), a Cayman Islands incorporated biopharmaceutical company focused on developing and commercializing innovative therapeutics and…